These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27478609)

  • 1. Incidence and outcome of encapsulating peritoneal sclerosis.
    Petrie MC; Traynor JP; Mactier RA
    Clin Kidney J; 2016 Aug; 9(4):624-9. PubMed ID: 27478609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulating peritoneal sclerosis in the new millennium: a national cohort study.
    Brown MC; Simpson K; Kerssens JJ; Mactier RA;
    Clin J Am Soc Nephrol; 2009 Jul; 4(7):1222-9. PubMed ID: 19541815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating risk of encapsulating peritoneal sclerosis accounting for the competing risk of death.
    Lambie M; Teece L; Johnson DW; Petrie M; Mactier R; Solis-Trapala I; Belcher J; Bekker HL; Wilkie M; Tupling K; Phillips-Darby L; Davies SJ
    Nephrol Dial Transplant; 2019 Sep; 34(9):1585-1591. PubMed ID: 30820552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis.
    Vidal E; Edefonti A; Puteo F; Chimenz R; Gianoglio B; Lavoratti G; Leozappa G; Maringhini S; Mencarelli F; Pecoraro C; Ratsch IM; Cannavò R; De Palo T; Testa S; Murer L; Verrina E;
    Nephrol Dial Transplant; 2013 Jun; 28(6):1603-9. PubMed ID: 23585587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group.
    Shroff R; Stefanidis CJ; Askiti V; Edefonti A; Testa S; Ekim M; Kavaz A; Ariceta G; Bakkaloglu S; Fischbach M; Klaus G; Zurowska A; Holtta T; Jankauskiene A; Vondrak K; Vande Walle J; Schmitt CP; Watson AR;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1908-14. PubMed ID: 23348882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and outcomes of encapsulating peritoneal sclerosis (EPS) and factors associated with severe EPS.
    Tseng CC; Chen JB; Wang IK; Liao SC; Cheng BC; Wu AB; Chang YT; Hung SY; Huang CC
    PLoS One; 2018; 13(1):e0190079. PubMed ID: 29293548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulating peritoneal sclerosis in an Italian center: thirty year experience.
    Vizzardi V; Sandrini M; Zecchini S; Ravera S; Manili L; Cancarini G
    J Nephrol; 2016 Apr; 29(2):259-267. PubMed ID: 26521254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant Decreasing Incidence of Encapsulating Peritoneal Sclerosis in the Dutch Population of Peritoneal Dialysis Patients.
    Betjes MG; Habib SM; Boeschoten EW; Hemke AC; Struijk DG; Westerhuis R; Abrahams AC; Korte MR
    Perit Dial Int; 2017; 37(2):230-234. PubMed ID: 28360369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of Post-Transplantation Encapsulating Peritoneal Sclerosis after Relatively Short Exposure to Peritoneal Dialysis: Prospective Analysis Using Repeated Abdominal CT Scanning.
    Abrahams AC; van Gelder MK; van der Veer JW; de Jong PA; van Leeuwen MS; Boer WH
    Perit Dial Int; 2017; 37(4):443-450. PubMed ID: 28676511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients.
    Alatab S; Najafi I; Pourmand G; Hosseini M; Shekarchian S
    Ren Fail; 2017 Nov; 39(1):32-39. PubMed ID: 27774831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of encapsulating peritoneal sclerosis (EPS) patients in a single center.
    Yamahatsu A; Hamada C; Kaneko K; Io H; Nakata J; Tomino Y
    Clin Exp Nephrol; 2015 Oct; 19(5):961-7. PubMed ID: 25612779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for encapsulating peritoneal sclerosis: Analysis of a 36-year experience in a University Hospital.
    Nakao M; Yamamoto I; Maruyama Y; Morishita M; Nakashima A; Matsuo N; Tanno Y; Ohkido I; Ikeda M; Yamamoto H; Yokoyama K; Yokoo T
    Nephrology (Carlton); 2017 Nov; 22(11):907-912. PubMed ID: 27556577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal effluent MMP-2 and PAI-1 in encapsulating peritoneal sclerosis.
    Lopes Barreto D; Struijk DG; Krediet RT
    Am J Kidney Dis; 2015 May; 65(5):748-53. PubMed ID: 25530106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study.
    Kawanishi H; Kawaguchi Y; Fukui H; Hara S; Imada A; Kubo H; Kin M; Nakamoto M; Ohira S; Shoji T
    Am J Kidney Dis; 2004 Oct; 44(4):729-37. PubMed ID: 15384025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study.
    Korte MR; Sampimon DE; Lingsma HF; Fieren MW; Looman CW; Zietse R; Weimar W; Betjes MG;
    Perit Dial Int; 2011; 31(3):269-78. PubMed ID: 21454391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulated peritoneal sclerosis: a single center, retrospective analysis of clinical manifestations, risk factors and prognosis.
    Koc Y; Basturk T; Sakaci T; Caglayan FB; Hasbal NB; Ahbap E; Sevinc M; Sinangil A; Ucar ZA; Nazif P; Islam M; Unsal A
    Minerva Urol Nefrol; 2018 Aug; 70(4):429-436. PubMed ID: 29478308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis.
    Otsuka Y; Nakayama M; Ikeda M; Sherif AM; Yokoyama K; Yamamoto H; Kawaguchi Y
    Clin Exp Nephrol; 2005 Dec; 9(4):315-319. PubMed ID: 16362159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulating peritoneal sclerosis: prevention and treatment.
    Kawanishi H; Moriishi M
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S289-92. PubMed ID: 17556321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis and therapeutic option of encapsulating peritoneal sclerosis.
    Kawanishi H
    Int J Artif Organs; 2005 Feb; 28(2):150-5. PubMed ID: 15770603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment.
    Yamamoto R; Nakayama M; Hasegawa T; Miwako N; Yamamoto H; Yokoyami K; Ikeda M; Kato N; Hayakawa H; Takahashi H; Otsuka Y; Kawaguchi Y; Hosoya T
    Adv Perit Dial; 2002; 18():131-4. PubMed ID: 12402604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.